Partners

PROMOMED is a leading innovative biopharmaceutical company with attractive growth potential in promising segments of the pharmaceutical market.

The Company has unique R&D Hub and manufacturing plant named BIOKHIMIK. This al-lows PROMOMED to develop innovative medicines, benefit from a full production cycle, be fast in responding to unmet needs in healthcare, implement up-to-date technology.

PROMOMED is ranked #1 in Obesity treatment segment being an expert in metabolic health therapy. The Company is #1 in Russia in terms of the number of clinical trials and medical studies in 2022-2023.

The Company has a diversified portfolio of more than 330 medicines and is represented in all TOP-10 of the biggest and fastest growing therapeutic areas in the local market, such as Onco, Diabetes, Obesity, Neuro, Rheuma, Pain, etc. More than 80% of PROMOMED products are listed as live-saving products in the local Essential Drug List.

Petrovax is a Russian full-cycle biopharmaceutical company with 28 years of successful experience.

The product portfolio includes original pharmaceutical products and vaccines, biotechnology drugs, and branded generics. The company has a research center and holds patents for new molecules and pharmaceutical manufacturing technologies in Russia and abroad. The company's complex for manufacturing of APIs and finished dosage forms is located in the Moscow region and operates in full compliance with the EAEU and EU GMP standards.

Petrovax is one of the largest Russian exporters of original medicinal products and vaccines, which are supplied to EAEU and EU countries.

Petrovax is implementing more than 10 international projects with leading pharmaceutical companies: Pfizer, Abbott, ISU ABXIS, Adimmune, Hengrui.

The development strategy focuses on providing patients with in-demand vaccines and medicines for the treatment of oncological and orphan diseases.

JSC BARS Group is a russian expert and developer of digital solutions for the state, business and individuals with a 30-year history and a staff of more than 2,700 employees. 25 company offices are located in the largest scientific and economic centers of Russia, including Kazan, Moscow, St. Petersburg, Novosibirsk, Kaliningrad, Vladivostok and others. BARS Group takes an active part in the development of the Digital Economy of Russia and creates digital solutions for the implementation of national projects, as well as in import substitution of software - 88 solutions are registered in a software register. All products of a BARS Group is carried out on its own digital platforms and components (BarsUp, Alpha BI, VODY, NXT Core, etc.), which are 100% russian developments. A wide range of both personal design services and application solutions has been created.

Research Center of Neurology is the largest scientific and clinical neurological institution in Russia and one of the largest in Europe. It combines the experience of highly qualified clinical specialists and researchers in the field of basic neuroscience, which allows the results of experimental research to be effectively implemented in practice. The Center was founded in 1945. It has 5 clinical and research institutes, employing about 1000 doctors and scientists, among which there are 4 full members and 3 corresponding members of the Russian Academy of Sciences.

Annually, the Research Center of Neurology provides care for over 6 thousand patients in the hospital and conducts about 40 thousand outpatient consultations of patients in need of expert diagnostics and rehabilitation. The Center covers the entire spectrum of neurological diseases and performs neurosurgical interventions, including minimally invasive and endoscopic brain and spinal cord surgery, as well as functional neurosurgery using MRI-guided focused ultrasound.

The Research Center of Neurology is a leader in the field of clinical and experimental neurology, the results of which are published in highly rated international journals. The Center is regularly supported by multiple grants and megagrants. Together with leading Russian manufacturers, the Center participates in the development of high-tech products for neurosurgery and neurorehabilitation. It is also a major educational base for all levels of neurological training.

Swixx BioPharma was founded to fully replace biopharma, OTC and medical device multinationals’ subsidiaries or business units in those countries, or therapeutic areas of CEE and beyond, that the multinational biopharma chooses not to enter, or to exit. With its expansion, Swixx BioPharma evolved into a professional and reliable partner with the highest standards in the areas where we operate.

At Swixx, we believe that everyone deserves access to the best medical solutions to live healthier and better lives. Although we are a pharmaceutical company without our own portfolio and research and development (R&D), we are committed to pursuing the standards and culture of a multinational pharmaceutical company.

We are highly experienced professionals, and our background is our strength. We joined forces and use our knowledge to constantly live up to our mission of providing access to the modern medicines of our partners.

For more information about Swixx, please visit: www.swixxbiopharma.com

SUN PHARMA is one of the world's leading pharmaceutical companies, one of the top 5 pharmaceutical companies in the world specializing in the production of generics. The company is represented by production sites and R&D centers around the world.

As a leading manufacturer of important and life-saving drugs, we care about the quality of life of people around the world.

We produce high quality, affordable medicines that are trusted by healthcare professionals and patients in more than 150 countries. The company's facilities produce more than 2,000 medicines in total. Innovative development and research contribute to the highly efficient development of Sun Pharma.

In Russia, the company is represented by commercial and production divisions. The company's product portfolio includes more than 270 drugs in various market segments.

The company's strong and reliable brands have a competitive advantage in various areas of medicine in the therapy of acute and chronic diseases, in the hospital segment and over-the-counter business.

The company has more than 32,000 full-time employees representing more than 50 nationalities

The Nizhpharm Group (formerly part of STADA) is one of the biggest Russian manufacturers of high-quality pharmaceuticals with a 105-year history.

The Group’s core business areas are as follows:

OTC products, dietary supplements and medical devices;

Rx segment including original formula medicines, specialty pharmaceuticals, and generics.

The Nizhpharm Group manages the operations of two manufacturing facilities: JSC Nizhpharm in Nizhny Novgorod and LLC Hemofarm in Obninsk. The Group's primary objective is to meet the local needs of patients as a trusted partner in Russia.

The Nizhpharm Group currently employs over 2,200 people.

Our product portfolio includes 120+ items. Approximately third of them are essential and vital drugs.

The Association of International Pharmaceutical Manufacturers (AIPM) was established in 1994. It represents the interests of the leading international pharmaceutical producers of the efficient, safe and high-quality medicines in the Russian Federation. To date AIPM comprises more than 60 international companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.

ECONAD® is a Russian brand creating a new category of

beverages

ECONAD® was developed under the concept of changing the dietary habits of the Russian consumer.

We offer a real alternative to the existing drinks on the market, which contain coloring agents and high sugar content, provoking disease and overweight.

ECONAD® is the first and the only carbonated drink on the Russian market based on whey and extracts of useful plants.

Baikal is a real wonder of the world. Anyone can try Baikal and recharge his energy today. On a picturesque shore, at the source of the Angara River, stands the Baikal Aqua factory, gifting people natural, exceptionally high-quality water straight from the depths, branded ‘Legend of Baikal’.

The water is extracted from deep layers of the lake with unique properties and flows through a water pass to the treatment plant. A closed technological production cycle, from blow moulding the bottles to filling them, eliminates the human impact and ensures top product safety.

Cisbaikalia is a land of nature reserves. A responsible producer, Baikal Aqua takes a proactive stance towards nature conservation, carefully monitoring the quality and composition of Baikal water. Our company researches the lake water’s properties, structure and an impact on human quality of life. We participate in projects to protect the lake from adverse environmental influences.

Daily Value is a functional nutrition brand that offers a wide range of products to support health and control blood sugar levels. The company creates healthy snacks and low-carb sweets aimed at maintaining health and energy balance. Daily Value brings unique solutions to the high diabetes and obesity market by offering innovative products for the entire family, including the Daily Value Kids line.

Daily Value is products without sugar, artificial additives, colors and preservatives, manufactured with an emphasis on natural composition and high quality standards; the products do not increase blood sugar levels.